Elevating Generic Drug Trust: An Expert's Blueprint for Consistent Quality Across the U.S. Supply Chain

Generic drugs are crucial for affordable healthcare in the U.S., yet public trust in their quality consistency remains a concern despite FDA assurances. Fuelled by recalls and supply chain complexities, a leading pharmaceutical policy expert proposes a comprehensive blueprint. This plan aims for a paradigm shift from reactive problem-solving to proactive quality assurance, designed to bolster confidence and guarantee consistent standards throughout the entire generic drug supply chain. This initiative is critical, given that generics account for nearly 90% of all prescriptions and save the healthcare system billions annually, highlighting the importance of unwavering quality to maintain their foundational role in medicine.